134 related articles for article (PubMed ID: 11564060)
1. Purple toe syndrome following anticoagulant therapy.
Raj K; Collins B; Rangarajan S
Br J Haematol; 2001 Sep; 114(4):740. PubMed ID: 11564060
[No Abstract] [Full Text] [Related]
2. Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome.
Talmadge DB; Spyropoulos AC
Pharmacotherapy; 2003 May; 23(5):674-7. PubMed ID: 12741443
[TBL] [Abstract][Full Text] [Related]
3. A case of unilateral purple toes due to warfarin.
Al-Niaimi F; Clark C
Clin Exp Dermatol; 2009 Jun; 34(4):527-8. PubMed ID: 19196305
[No Abstract] [Full Text] [Related]
4. Thrombosing arteriosclerosis; result of long-term anticoagulant therapy.
DEDICHEN J
Br Med J; 1956 Nov; 2(5000):1038-9. PubMed ID: 13364383
[No Abstract] [Full Text] [Related]
5. Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction.
Drapkin A; Merskey C
JAMA; 1972 Oct; 222(5):541-8. PubMed ID: 4117261
[No Abstract] [Full Text] [Related]
6. Anticoagulants.
Forbes CD; Prentice CR
Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
[No Abstract] [Full Text] [Related]
7. Rapidly progressive glomerulonephritis treated with anticoagulants.
Arieff AI; Pinggera WF
Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
[No Abstract] [Full Text] [Related]
8. [Anticoagulant therapy and prophylaxis in arterial vascular diseases].
Heine H; Schmidt H; Mach H; Jaruszewski H
Dtsch Gesundheitsw; 1971 May; 26(19):861-8. PubMed ID: 5578165
[No Abstract] [Full Text] [Related]
9. The management of adequate anticoagulant therapy and its complications.
Royston GR
Vasc Dis; 1966 Oct; 3(5):295-304. PubMed ID: 4162445
[No Abstract] [Full Text] [Related]
10. [Comparative anti-inflammatory action of anticoagulant substances. Mode of action of phenylindanedione].
Fontaine L; Grand M; Quentin Y; Merle S
Med Pharmacol Exp Int J Exp Med; 1965; 13(3):137-54. PubMed ID: 4157600
[No Abstract] [Full Text] [Related]
11. Control of long-term anticoagulant therapy.
Lawson DH; McDonald GA
Scott Med J; 1967 Apr; 12(4):163-5. PubMed ID: 6034271
[No Abstract] [Full Text] [Related]
12. Report on long term therapy with anticoagulants.
Owren PA
Thromb Diath Haemorrh Suppl; 1964; 12():131-2. PubMed ID: 5006807
[No Abstract] [Full Text] [Related]
13. [Warfarin switch from fluindione in elderly patients].
Peyro Saint Paul L; Martin J; Moslemi I; Le Hello C; Le Querrec A
Presse Med; 2014 Feb; 43(2):221-3. PubMed ID: 24184283
[No Abstract] [Full Text] [Related]
14. [Arterial diseases of the lower limbs. Treatment with anticoagulants. Value of their long-term use].
Jouve A; Pierron J; Avril P; Nakache A
Nouv Presse Med; 1972 Sep; 1(34):2250-2. PubMed ID: 4628245
[No Abstract] [Full Text] [Related]
15. Improved control of long-term anticoagulant therapy.
Eastham RD
Br Med J; 1968 May; 2(5601):337-40. PubMed ID: 5648973
[No Abstract] [Full Text] [Related]
16. Warfarin-related purple toes syndrome and cholesterol microembolization.
Hyman BT; Landas SK; Ashman RF; Schelper RL; Robinson RA
Am J Med; 1987 Jun; 82(6):1233-7. PubMed ID: 3605140
[TBL] [Abstract][Full Text] [Related]
17. [Advice for patients taking oral anticoagulants (coumadin or Previscan)].
Rev Prat; 2007 Apr; 57(7):768. PubMed ID: 17626322
[No Abstract] [Full Text] [Related]
18. Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment.
Sallah S; Thomas DP; Roberts HR
Thromb Haemost; 1997 Aug; 78(2):785-90. PubMed ID: 9268171
[No Abstract] [Full Text] [Related]
19. [Indications for and hazards of anticoagulant therapy].
Straub PW
Schweiz Med Wochenschr; 1970 Apr; 100(16):686-91. PubMed ID: 4258885
[No Abstract] [Full Text] [Related]
20. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
Mooney T; Joseph P
Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
